Evaluation of antihypercholesterolemic activity of antichol against cholesterol cocktail induced hypercholesterolemia in rats

Pharmacologyonline

Volumn 3, Issue , 2009, Pages 470-478

  Pamidiboina, Venu ^a   Chikkaboraiah, Satheesh Hanakere ^a   Razdan, Rema ^b   Krishnamurthy, Praveen Thaggikuppe ^c  

^a Visveswarapura Institute of Pharmaceutical Sciences   (India)

^b AL AMEEN COLLEGE OF PHARMACY   (India)

^c JSS COLLEGE OF PHARMACY   (India)

Author keywords

Antichol; Cholesterol; Hyperlipidemia; Lipidperoxidation; Lovastatin; Metabolic disorder

Indexed keywords

ANTICHOL; CATALASE; CHOLESTEROL; COMMIPHORA MUKUL EXTRACT; CURCUMA LONGA EXTRACT; EMBLICA OFFICINALIS EXTRACT; GARCINIA CAMBOGIA EXTRACT; GLUCOSE; GLUTATHIONE; HERBACEOUS AGENT; HYPOCHOLESTEROLEMIC AGENT; KINO EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLANT EXTRACT; SUPEROXIDE DISMUTASE; TERMINALIA ARJUNA EXTRACT; TERMINALIA CHEBULA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMMIPHORA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; FATTY LIVER; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; KINO; LIVER LEVEL; MALE; NONHUMAN; PTEROCARPUS; RAT;

EID: 75449103990     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Asha SK, Vijayalakshmi NR. Impact of certain flavonoids on lipid profiles - potential action of Garcinia Combogia flavonoids. Phytother Res 2001; 15: 395-400.
2. Ashfaq, S., Abramson, J.L., Jones, D.P., Rhodes, S.D., Weintraub, W.S., Hooper, W.C., Vaccarino, V., Harrison, D.G. and Quyyumi, A.A. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am College Cardiol 2006; 47: 1005-1011.
3. Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C. and La Du, B. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 1998; 18:1617-1624.
4. Babu PS, Stanely Mainzen prince P. Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin - induced diabetic rats. J Pharm Pharmacol 2004; 56(11): 1435-1442.
5. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 1990; 87: 1620-1624.
6. Farboodniay Jahromi MA, Anil B. Antihyperlilpidemic effect of flavonoids from Pterocarpus marsupium. J Nat Prod 1993; 56(7): 989-994.
7. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci 1980; 77: 2214-2218.
8. Ganju L, Karan D, Chandra S, Srivastava KK, SawhneyRC, Selvamurthy W. Immnomodulatory effects of agents of plant origin. Biomed Pharmacother 2003; 57(7): 296-300.
9. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981; 103: 181-190.
10. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci 1979; 76: 333-337.
11. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein induced cytotoxicity. Arteriosclerosis 1983; 3: 215-222.
12. Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest 1977; 59:149-158.
13. Miquel J, Bernd A, Sempere JM, Diaz-Alperi, Ramirez. The Curcuma antioxidants: Pharmacological effects and prospects for future clinical use. Arch Gerontal Geriatric 2002; 34(1): 37- 46.
14. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci 1985; 82: 5949-5953.
15. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883-887.
16. Saran M, Michel C, Bors W. Reaction of NO with O2·- implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic Res Commun 10: 221-6.
17. Schaffner T, Taylor K, Bartucci EJ, Fischer-Dzoga K, Beeson JH, Glagov S, and Wissler RW. 1980. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol 1990; 100: 57-80.
18. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
19. Urizar Nancy L, Moore David D. Gugulipid, A natural cholesterol lowering agent. Annu Rev Nutr 2003; 23:303-313.
20. Yagi K. Increased serum lipid peroxides initiates atherogenesis. Bioassays 1984; 1: 58-60.